Clostridium difficile is the most common hospital acquired pathogen in the USA, and infection is, in many cases, fatal. Toxins A and B are its major virulence factors, but expression of a third toxin, known as C. difficile transferase (CDT), is increasingly common. An adenosine diphosphate (ADP)-ribosyltransferase that causes actin cytoskeletal disruption, CDT is typically produced by the major, hypervirulent strains and has been associated with more severe disease. Here, we show that CDT enhances the virulence of two PCR-ribotype 027 strains in mice. The toxin induces pathogenic host inflammation via a Toll-like receptor 2 (TLR2)-dependent pathway, resulting in the suppression of a protective host eosinophilic response. Finally, we show that restoration of TLR2-deficient eosinophils is sufficient for protection from a strain producing CDT. These findings offer an explanation for the enhanced virulence of CDT-expressing C. difficile and demonstrate a mechanism by which this binary toxin subverts the host immune response.
T he Gram-positive anaerobe Clostridium difficile causes mild to severe antibiotic-associated diarrhoea, pseudomembranous colitis, toxic megacolon and death 1, 2 . The Rho-glucosylating toxins A and B (TcdA and TcdB) induce host cell death and profound inflammation and are required for symptomatic infection [3] [4] [5] [6] [7] . Production of the binary toxin C. difficile transferase (CDT) in addition to toxins A and B by C. difficile is associated with higher mortality, increased peripheral white blood cell count and elevated risk of recurrence in clinical studies [8] [9] [10] . CDT-expressing strains have also become increasingly common over the last ten years, paralleling the overall increase in incidence and severity of Clostridium difficile infection (CDI), and now account for up to 20% of isolates in the hospital setting [11] [12] [13] [14] .
CDT consists of two components, which act cooperatively to intoxicate cells 14, 15 . CDTb, the binding component of CDT, is produced as a precursor protein and requires proteolytic cleavage before intoxication. Following cleavage, CDTb forms a heptamer and associates with the lipolysis stimulated lipoprotein receptor (LSR) 16, 17 . This receptor is highly expressed within the liver, small intestine, colon and various other tissues, and is thought to be involved in the uptake and removal of lipoproteins and in the formation of tricellular tight junctions 18, 19 . Following formation of the CDTb heptamer and LSR binding, CDTa, the enzymatic component of CDT, binds the CDTb heptamer. This complex is endocytosed, and endosomal acidification triggers insertion of the CDTb heptamer into the endosomal membrane, through which CDTa is released into the cytoplasm 20 . CDTa then transfers an ADP-ribose moiety to globular actin, which subsequently acts as a capping protein to prevent actin filament elongation. This results in collapse of the actin cytoskeleton, allowing the formation of microtubule protrusions on the surface of host cells that are thought to increase C. difficile adherence 21, 22 .
Although CDT production is associated with more severe disease, the role of CDT during infection is not well understood. In a hamster model of CDI, CDT was shown to enhance virulence in the presence of toxin A, but not toxin B. In humans, the intensity of the host inflammatory response is critical in determining disease outcome and in murine models, innate IL-23 production is detrimental during infection [23] [24] [25] [26] . Toxins A and B shift the immune response towards this pathogenic inflammatory state by inducing IL-1β secretion via activation of the inflammasome 26, 27 . Therefore, we hypothesized that CDT may play an additional role during infection by influencing host inflammatory signalling.
To investigate the role of CDT during diease, here we use isogenic CDT mutants of two distinct PCR-ribotype 027 strains in a mouse model of C. difficile colitis (R20291 and M7404). Both strains are human isolates that express toxins A and B as well as CDT, but R20291 was originally isolated from an outbreak in the UK and M7404 originated in Canada 28, 29 . In this system, we show that CDT is a true virulence factor capable of enhancing disease severity in conjunction with toxins A and B. We report that CDT increases pathogenic host inflammation via a novel Toll-like receptor-2-dependent pathway, which is required for suppression of a protective host eosinophilic response during infection.
CDT production enhances C. difficile virulence
To test the role of CDT during disease, we infected mice with the PCR-ribotype 027 strain R20291 or one of the isogenic mutants R20291 CdtB− (lacking the binding component of CDT) or R20291 CdtA− (lacking the enzymatic component of CDT) 28, 30 . Infection with R20291 led to significantly greater mortality and weight loss than infection with an equivalent dose of R20291 CdtA− or CdtB− (60% survival versus 100% survival, n = 14, P = 0.001, Fig. 1a,b and Supplementary Fig. 1a-c) . By day 3 of infection, mice infected with the CDT mutant strains began to recover weight and showed decreased clinical signs. At the same time point, groups infected with R20291 displayed increased weight loss and a high mortality rate. Thus, we concluded that the mutants lacking CDT were significantly attenuated at this dose.
We confirmed this phenotype in a second PCR-ribotype 027 strain, M7404, using an isogenic mutant lacking CdtA (M7404 CdtA−) as well as a third, CdtA complemented strain (M7404 CdtAComp) 29 . Although we initially used a wide range of infectious doses (1 × 10 5 to 1 × 10 7 c.f.u. per mouse) in an attempt to determine an LD50 inoculum, infection with M7404 did not result in significant mortality in our model. However, we did observe differences in weight loss and clinical scores between the groups. We found that M7404 CdtA-caused significantly less weight loss and lower disease severity scores on days 2 and 3 of infection than either the wild type or CDT complemented strains ( Fig. 1c,d) . These data suggest that although M7404 and R20291 may inherently differ in virulence in this model, CDT was able to enhance disease severity in both strains.
To further characterize the differences in disease manifestation in the presence or absence of CDT, we focused on strain R20291 as a model of severe C. difficile infection due to its significant mortality. The R20291 CdtB− mutant was chosen as a comparison to eliminate any potential effects of the known pore-forming ability of CDTb alone 18 . Haematoxylin and eosin (H&E) stained histopathological sections of the caeca from both groups were examined ( Fig. 1e,f ). Sections taken from mice infected with R20291 displayed significantly more overall tissue damage in the form of epithelial barrier disruption (characterized by disorganization and sloughing of epithelial cells), submucosal oedema and lumenal exudate than those infected with R20291 CdtB− ( Supplementary Fig. 1d ). We next measured the production of toxins A and B in these mice on day 3 of infection, as expression of these major virulence factors could explain the differences observed in tissue pathology. However, we did not observe significant differences ( Supplementary Fig. 1e ), suggesting that the mortality rates were driven by other factors. We also assessed C. difficile burden in caecal contents on day 3 of infection, but did not observe a difference at this time point ( Supplementary  Fig. 1f ). We then assessed translocation of commensals from the gut to other organs as a possible consequence of epithelial damage. This process has been suggested to drive mortality in some models of CDI 25 . However, we did not observe differences in the translocation of commensals to the liver or spleen ( Supplementary Fig. 1g ). We conclude that tissue pathology due to CDT may influence disease outcome independently of toxin A and B production, C. difficile burden or liver commensal burden.
CDT causes increased inflammation
Based on clinical data demonstrating a correlation between the host inflammatory response and disease severity, we hypothesized that a systemic inflammatory response could result from increased tissue pathology and contribute to mortality during infection with R20291.
To investigate this possibility, we quantified the inflammatory cytokines IL-1β and IL-6 within the caecal tissue of C57BL6 mice infected with R20291 or R20291 CdtB− on day 3 post infection. Both IL-1β and IL-6 are known to be highly upregulated during CDI and to influence the type of immune response that develops. We found that R20291 induced significantly more caecal IL-1β and IL-6 than R20291 CdtB− ( Fig. 2a,b) . Similarly, we observed significantly elevated serum IL-6 in R20291-infected mice (Fig. 2c ). These results suggest that CDT production by R20291 results in a stronger local and systemic inflammatory response within the murine host.
We next sought to determine how CDT signalling directly influences inflammatory cytokine production. To investigate this, we exposed bone marrow derived dendritic cells (BMDCs) generated from C57BL6 mice to purified CDT in the presence or absence of 2 ng ml -1 toxins A and B, and measured the amount of IL-1β secreted into the culture medium as a readout of inflammatory cytokine production ( Fig. 2d ). As we and other groups have shown previously, toxins A and B are sufficient to activate the inflammasome at this concentration, but a prior 'priming' signal is required for robust IL-1β secretion 27 . We found that CDT alone did not induce IL-1β secretion at this relatively long time point, even at a much higher concentration than toxins A and B (200 ng ml -1 ). However, CDT did enhance IL-1β release in the presence of toxins A and B. These data suggest that CDT acts as a priming signal for inflammasome activation by toxins A and B. To investigate this further, we examined the ability of CDT to activate NFκB in a RAW macrophage reporter cell line. CDT alone was able to significantly activate NFκB over mock treated cells ( Fig. 2e ). Additionally, CDT induced significant pro-IL-1β gene expression in C57BL6 BMDCs as measured by quantitative reverse transcription polymerase chain reaction ( Fig. 2f ). To determine whether this phenotype was specific to CDT activity, we used anti-CDT targeted nanobodies, which have previously been demonstrated to block CDT intoxication 31 . At concentrations of 200 ng ml -1 (12 nM) and 20 ng ml -1 (1.2 nM), the anti-CDTa and anti-CDTb nanobodies both significantly decreased the amount of IL-1β secreted by BMDCs ( Fig. 2g ). Thus, we conclude that exposure to CDT is sufficient to activate NFκB and enhance inflammatory cytokine production. IL-6 IL-6 (serum)
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CDT suppresses protective colonic eosinophilia
Because cytokine production shapes the immune response by influencing cell development, recruitment, proliferation and survival, we next used flow cytometry to examine the composition of effector cells in the colon during murine infection with R20291 and R20291 CdtB−. As expected, neutrophils (CD45 + CD11b + Ly6G + Ly6C + ) dominated the innate compartment of both infected groups, representing roughly 20% of live cells in the colon ( Fig. 3a -c). Monocytes (CD45 + CD11b + Ly6C hi Ly6G − ) were also significantly elevated in the colon of both infected groups compared to uninfected, antibiotic-treated controls. However, no difference was observed between neutrophils and monocytes in R20291 versus R20291 CdtB− infected groups, either as a percentage of live cells or by total cell number, suggesting that differences in neutrophil and monocyte recruitment were not responsible for infection outcome. In contrast, eosinophils were significantly elevated in R20291 CdtB− infected mice compared to R20291 infected animals ( Fig. 3a-c ). As with neutrophils and monocytes, eosinophils were significantly increased in both groups compared to uninfected, antibiotic-treated controls. Studies from our laboratory demonstrated a protective role for eosinophils after recombinant IL-25 administration 32 . Because the Figure 3 | CDT production suppresses protective colonic eosinophilia. a, Mice infected with the indicated strain, or uninfected and treated with antibiotics only (Abx) were killed on day 3. Colon tissue was isolated and processed to a single cell suspension and stained for flow cytometry. Representative flow plots depicting neutrophils and eosinophils are shown (two independent experiments, n = 10). b,c, Eosinophils (CD45 + CD11b + SiglecF + ), monocytes (CD45 + CD11b + Ly6C hi ) and neutrophils (CD45 + CD11b + Ly6G + ) were quantified. All three cell types are significantly elevated in both infected groups compared to Abx-treated controls (data are combined from two independent experiments, n = 10). d, Weight loss and percentage live colon eosinophils were compared using data combined from four independent experiments (n = 17). e, Colonic eosinophils were depleted using 40 µg of an anti-SiglecF targeted antibody or an isotype control antibody one day before and one day following infection with C. difficile. Animals were monitored for clinical symptoms and humanely euthanized when required. Data are combined from two independent experiments (n = 13). *P < 0.05, **P < 0.01, ***P < 0.001 by Mann-Whitney test (b,c), linear regression (d) or Kaplan-Meier curve (e). NS, not significant. Error bars represent s.e.m.
protected, R20291 CdtB− infected group showed increased eosinophils compared to R20291, we hypothesized that high eosinophil numbers may correlate with protection from mortality. To examine this more closely, we used weight loss as a measure of disease severity and found a significant correlation between increased weight loss and lower eosinophil percentages, suggesting that eosinophils were associated with protection from disease ( Fig. 3d ).
We next sought to determine whether eosinophils were causative in protection or merely associated with a better outcome. To address this question, we depleted eosinophils in mice infected with R20291 or R20291 CdtB− using an anti-SiglecF targeted antibody that results in eosinophil apoptosis 33 (Fig. 3e and Supplementary  Fig. 2 ). As expected, animals infected with R20291 CdtB− and treated with an isotype control antibody were relatively protected from mortality. In contrast, depletion of eosinophils with anti-SiglecF before and during infection with R20291 CdtB− significantly enhanced mortality. In R20291 infected mice, depletion of eosinophils did not significantly enhance mortality, perhaps because eosinophil counts are already relatively low in this group. Overall, these results demonstrate that an eosinophilic response is protective during CDI and that CDT production by a PCR-ribotype 027 strain has a suppressive effect on eosinophils in the colon, probably contributing to the enhanced virulence of this strain.
CDT induces apoptosis of blood eosinophils
Next, we investigated the cause of the decrease in eosinophils observed in R20291 infected mice. We hypothesized that eosinophil recruitment signals or growth factors would be decreased in mice infected with the CDT-producing strain. However, R20291 and R20291 CdtB− infected animals demonstrated equivalent levels of the eosinophil-specific chemokines eotaxin-1 and eotaxin-2 ( Fig. 4a ). Eosinophil-promoting growth factors, such as IL-5, granulocyte macrophage colony-stimulating factor (GM-CSF), IL-13, IL-33 and thymic stromal lymphopoietin (TSLP), were similar or elevated in R20291 infected mice, suggesting that these factors were not responsible for the observed decrease in eosinophils ( Supplementary Fig. 3a ,b) [34] [35] [36] .
Because the expression of CCR3, the cognate receptor for the eotaxins, has been shown to influence eosinophil recruitment 37 , we hypothesized that different levels of this receptor could influence responsiveness to equivalent signals. We evaluated the eosinophil surface expression of CCR3 during infection with R20291 and R20291 CdtB− (Fig. 4b ) by gating on CD45 + CD11c − CD11b + SiglecF + cells and assessing CCR3 staining. We observed a significant decrease in the number of CCR3 + eosinophils in the colon of R20291 infected mice compared to R20291 CdtB− infected animals. These results could indicate that eosinophils in R20291 infected mice are less responsive to eotaxins, thereby affecting recruitment to the gut. However, CCR3 upregulation is also associated with eosinophil maturity and egress from the bone marrow 38 . Additionally, both CCR3 + and CCR3 − eosinophils have been identified within the colon, suggesting that this receptor is not absolutely required for colonic eosinophil recruitment 33 . Therefore, we hypothesized that a decrease in colonic CCR3 + eosinophils could also result from other causes, such as a decrease in the number of mature eosinophils in the colon due to cell death.
To further investigate this possibility, we sought to determine where the eosinophil defect began. Eosinophils develop within the bone marrow from eosinophil progenitors (EoPs), defined as Lineage − , CD34 + , Sca-1 − , IL-5Rα + , cKit int cells 33, [39] [40] [41] (Supplementary Fig. 3c ). We did not observe a significant difference in the number of bone marrow EoPs in R20291 or R20291 CdtB− infected mice (Fig. 4c) , consistent with the similar levels of eosinophil-promoting growth factors in these groups. When we examined mature bone marrow eosinophils, we noted that both infected groups had significantly more eosinophils than antibiotic-treated controls (Fig. 4d ). However, there was no significant difference in the number of mature eosinophils between the two infected groups. In contrast, when we examined eosinophil numbers in the peripheral blood of infected mice, we noted a significantly decreased percentage of live eosinophils in R20291 infected mice (Fig. 4e ). This mirrored the phenotype observed in the colon and indicated that the eosinophil defect was systemic, but did not originate in the bone marrow, suggesting that a recruitment defect was not responsible for the observed decrease in colonic eosinophils.
We also observed that a higher percentage of blood eosinophils in mice infected with R20291 stained positive for Annexin V, a marker of apoptosis, which could contribute to the observed defect in mature eosinophils (Fig. 4f ). Taken together, these data suggest that eosinopoiesis functions similarly within both groups of infected mice, but that mature eosinophils that exit the bone marrow in R20291 infected mice undergo increased rates of apoptosis, resulting in the observed decrease in live eosinophils in both the blood and colon of these animals.
CDT recognition by TLR2 mediates eosinophil suppression
Because activation of NFκB is classically associated with pattern recognition receptor (PRR) signalling, we next asked whether these signalling pathways were involved in the recognition of CDT to mediate eosinophil apoptosis. We analysed the ability of BMDCs generated from whole bone marrow of TLR2 −/− , TLR4 −/− and TLR5 −/− mice to secrete IL-1β following exposure to CDT and Toxins A and B. We found that TLR2 −/− BMDCs were essentially unable to respond to CDT, suggesting that this pathway may be involved in CDT recognition (Fig. 5a ). To corroborate the role of TLR2, we treated wild-type C57BL6 BMDCs with CDT and toxins A and B following pre-treatment with an anti-TLR2 neutralizing antibody or an isotype control. The anti-TLR2 antibody significantly reduced the release of IL-1β ( Fig. 5b) . To determine whether this interaction occurs in vivo, we next infected TLR2 −/− mice alongside C57BL/6 wild-type controls with R20291 as well as R20291 CdtB−. Neither TLR2 −/− nor C57BL/6 mice experienced significant mortality after infection with R20291 CdtB− (Fig. 5c ). However, TLR2 −/− mice were significantly protected from mortality after infection with CDT-producing R20291, suggesting that TLR2 signalling enhances C. difficile virulence in the presence of CDT (Fig. 5c ).
We next asked whether TLR2 may be involved in the marked decrease in colonic eosinophils observed during infection with R20291. We assessed eosinophilia in the colonic lamina propria via flow cytometry and found that TLR2 −/− mice displayed significantly higher numbers of colonic eosinophils than wild-type mice after infection with R20291. In contrast, no significant difference was noted after infection with R20291 CdtB−, suggesting that the increase in colonic eosinophils in TLR2 −/− mice specifically occurred in the presence of CDT (Fig. 5d ). These results suggest that recognition of CDT via TLR2 leads to suppression of eosinophilia in the colon and enhanced mortality.
TLR2 −/− eosinophils protect against CDT + C. difficile
To determine whether preventing TLR2 signalling on a subset of eosinophils was sufficient to provide protection from R20291, we performed an adoptive transfer of bone marrow derived eosinophils (BM Eos) generated from either C57BL/6 or TLR2 −/− mice. BM Eo cultures routinely consisted of greater than 75% CD45 + CD11b + SiglecF + SSC hi mature eosinophils ( Supplementary Fig. 4a ). Mice that received TLR2 −/− BM Eos were significantly protected from R20291-mediated mortality compared to mice that received C57BL/6 BM Eos and to wild-type controls (Fig. 5e ), suggesting that restoration of eosinophils is protective only when the eosinophils are unable to signal via TLR2. We next investigated the possibility that this could be due to direct killing of eosinophils by CDT. We incubated BM Eos with CDT in vitro and assessed cell death by Live/dead and Annexin V staining measured by flow cytometry.
Treatment with CDT did not significantly enhance the number of detected apoptotic (Fig. 5f ) or dead eosinophils ( Supplementary  Fig. 4b) . Similarly, CDT did not enhance apoptosis or death of eosinophils when added in conjunction with toxins A and B ( Supplementary Fig. 4c,d) . Therefore, we conclude that direct killing of eosinophils by CDT is unlikely, suggesting that TLR2 signalling on eosinophils influences host survival by another mechanism, perhaps by modifying the protective function of these cells or their recruitment capability.
Discussion
Despite understanding the enzymatic function of CDT, the role of this toxin in enhancing C. difficile virulence remains incompletely characterized, and the influence of CDT on the host immune response has not been examined. We found that CDT was able to enhance the virulence of two PCR-ribotype 027 C. difficile strains, resulting in increased tissue pathology. CDT skewed the host inflammatory response by suppressing protective eosinophils within the colon and blood via the indirect induction of eosinophil apoptosis. Additionally, purified CDT was able to activate NFκB and induce inflammatory IL-1β production in conjunction with toxins A and B. This required TLR2 signalling, and TLR2-deficient mice were protected against the CDT-producing strain R20291, correlating with increased colonic eosinophils compared to wild-type mice. Finally, adoptive transfer of TLR2-deficient eosinophils was sufficient to protect mice against CDT+ R20291, confirming an unexpected role for eosinophils in protection from CDI.
Although we have demonstrated that CDT is able to activate NFκB and enhance inflammatory cytokine production, it is unclear where this signalling occurs in vivo. CDT may intoxicate epithelial cells to promote recruitment of immune cells, which may in turn enhance the inflammatory response. Alternatively, CDT may act directly on immune cells to enhance NFκB activation. The role of the lipolysis-stimulated lipoprotein receptor in mediating an immune response is also unknown. It is conceivable that LSR and TLR2 mediate separate pathways in response to CDT. Alternatively, these receptors may cooperate to permit CDT recognition and intoxication. Another major question concerns the mechanism of eosinophil killing by CDT. Although our data suggest that CDT does not directly kill eosinophils, intoxication by CDT and the subsequent increase in inflammatory cytokine production by innate cells may shape the inflammatory environment to support eosinophil apoptosis. Indeed, innate inflammation has long been known to suppress eosinophilia by unknown mechanisms 42, 43 . TLR2-dependent eosinophil suppression is also not unprecedented, as multiple groups have reported in different murine models of allergic inflammation [44] [45] [46] .
Administration of a TLR2 agonist has been shown to reduce eosinophilia by inducing T cell apoptosis in a model of allergic conjunctivitis, as well as by enhancing T regulatory cells and inducing Th1
cytokines in murine asthma models. It remains to be investigated whether these mechanisms underlie eosinophil suppression during CDI. The protective role of eosinophils is similarly unknown, and clarifying how TLR2 signalling impacts the function of these cells may provide clues to their activity during infection.
Understanding the mechanism by which CDT enhances C. difficile virulence is essential to understanding the virulence of PCR-ribotype 027 strains and other hypervirulent strains that express CDT. These isolates are increasingly common, and their spread is probably contributing to the overall increase in CDI incidence and severity. Our data clarify the protective role eosinophils play during CDI and suggest that targeting CDT in the development of vaccines and therapeutic inhibitors is essential to successfully treating infection with these strains. Our knowledge of the C. difficile virulence factors that result in pathogenic immune responses during CDI continues to evolve, presenting new potential drug targets for treating this common and life-threatening infection.
Methods
Bacterial strains and culture. C. difficile strains R20291 CdtA− and R20291 CdtB− were generated using the ClosTron system, and functional inactivation of the targeted genes was confirmed by western blot, as described previously 28 . Strains M7404 CdtA− and M7404 CdtComp were generated using the targetron system as previously described 29 . To prepare the infection inoculum, strains were inoculated onto brain heart infusion (BHI) agar supplemented with the appropriate selective antibiotic from frozen stocks and incubated at 37°C overnight in an anaerobic work station (Shel Labs). Single colonies were inoculated into BHI medium supplemented with cycloserine and cefoxitin (C. difficile supplement, Sigma) and grown anaerobically overnight at 37°C. The next day, cultures were spun for 1 min at 6,000g and washed twice in anaerobic PBS. The optical densities of the cultures were measured, and the culture density was adjusted to 1 × 10 8 c.f.u. ml -1 (R20291 strains) or 2 × 10 6 c.f.u. ml -1 (M7404 strains) in sterile, anaerobic PBS. Syringes were loaded with the inoculum and sealed in airtight bags before and during transport to the infection facility. Mice received 100 µl of inoculum each by oral gavage. To enumerate C. difficile in caecal samples, the caecal contents were resuspended by weight in pre-reduced PBS. Re-suspended caecal contents were serially diluted in PBS and plated on BHI agar supplemented with 1% sodium taurocholate and 1 mg ml -1 D-cycloserine and 0.032 mg ml -1 cefoxitin (Sigma) before incubation overnight, anaerobically at 37°C. Liver bacterial burden was determined by homogenizing whole liver samples in sterile, aerobic PBS. Liver homogenate was serially diluted and plated on non-selective BHI agar before incubation, aerobically overnight at 37°C. Liver c.f.u. are reported according to liver sample weight.
CDT complementation. The recombinant plasmid used for complementation of the cdtA mutant was pJIR3107 (described previously 47 ). C. difficile strains were grown in tryptone yeast (TY) broth (3.0% tryptone, 2.0% yeast extract and 0.1% sodium thioglycollate) at 37°C in a Don Whitley A35 anaerobic work station in an atmosphere of 10% (vol/vol) H 2 , 10% (vol/vol) CO 2 and 80% (vol/vol) N 2 . Toxins were partially purified and concentrated eight-fold from 72 h C. difficile culture supernatants by methanol-chloroform precipitation 48 . Protein concentrations were determined using the BCA protein assay kit (Pierce) according to the manufacturer's instructions. Concentrated supernatant proteins (10 µg) were separated by 10% (wt/vol) SDS-PAGE and transferred onto a nitrocellulose membrane (Whatman). Membranes were probed as previously described 29 . Briefly, CDTa and CDTb were detected using a CDTa-specific antibody and a C. perfringens Ib-specific antibody that is cross-reactive with CDTb 49 , respectively. CDTa and CDTb antibodies were detected using horseradish peroxidase conjugated anti-rabbit goat antibodies (Millipore) The Western Lightning Chemiluminescence reagent kit (Perkin-Elmer) was used to detect the blots, following the manufacturer's instructions, and blots were recorded by exposure to X-ray film (Fujifilm).
Cell culture. Murine BMDCs were generated as previously described with minor modifications 50 . Briefly, femurs and tibia were removed and bone marrow was flushed with PBS. Cells were counted and viability assessed by Trypan Blue staining and resuspended in RPMI 1640 media (Life Technologies) containing 10% fetal bovine serum (FBS), 2 mM L-glutamine and 100 U ml -1 penicillin and 100 U ml -1 streptomycin. Media were supplemented with 10 ng ml -1 GM-CSF (Peprotech) and 55 µM β-mercaptoethanol (Gibco) and 3 × 10 6 cells were seeded into a T75 vent cap tissue culture flask. Cells were cultured for 7 days and supplemented with fresh media on days 2 and 4. On day 7, cells were collected for stimulation. For stimulation, BMDCs were detached with a cell scraper and resuspended to 1.1 × 10 6 cells per ml in fresh media. Cell suspension (180 µl) was added to each well of a 96-well plate. Cells were stimulated with the indicated concentrations of CDT or toxins A and B in a total volume of 20 µl complete medium. After the indicated incubation time, cells were spun down, and the supernatant was removed and frozen at −80°C for later analysis. For cell stimulation, TLR-ligand tested lipopolysaccharide (Sigma) was used as a positive control. Anti-TLR2 antibody and IgG isotype control were obtained from Invivogen and eBioscience, respectively. Anti-CDT nanobodies were generated as previously described 31 . Raw Blue NFκB reporter cells were obtained from Invivogen and grown in DMEM supplemented with 4.5 g l -1 glucose and 10% FBS. Cell responsiveness to TLR stimulation and mycoplasma status was assessed by Invivogen. For stimulation, cells were detached using a cell scraper and resuspended to a density of 5.5 × 10 5 cells per ml in fresh media. The cell suspension (180 µl) was added to each well of a 96-well plate, and cells were stimulated with CDT as indicated. Secreted embryonic alkaline phosphatase (SEAP) secretion was quantified by spinning down cells, removing the culture supernatant and incubating 50 µl of supernatant with 150 µl of Quanti-Blue detection media (Invivogen) for 30 min at 37°C before reading in a spectrophotometer. For treatment of BM Eos with CDT, cells were collected from culture on day 10 and plated in 96-well plates in fresh media before addition of CDT and neutralizing antibodies. Cells were collected at 8 h and stained for flow cytometry to assess eosinophil viability.
Toxins. Purified CdtA and CdtB were expressed in Bacillus megaterium as previously reported 22 . CdtB was previously activated by protease cleavage (0.2 µg of trypsin per µg of protein for 30 min at 37°C) before addition of trypsin inhibitor. The mock buffer used contained identical concentrations of trypsin and trypsin inhibitor to mimic the purified proteins. Purified toxins A and B were purified from C. difficile strain VPI 10463 and were obtained as a gift from Techlab. Toxins were detected within caecal contents using the C. difficile TOXA/B enzyme-linked immunosorbent assay (ELISA) according to the manufacturer's instructions (also donated by Techlab).
Cytokine detection. IL-1β and IL-6 were detected in protein supernatants from BMDCs, serum and tissue lysates using the Mouse IL-1β and IL-6 Ready-Set-Go! ELISA kit (eBioscience) according to the manufacturer's instructions. Eotaxin-1 and eotaxin-2 were detected in caecal lysates using R&D Systems DuoSet ELISA kits according to the manufacturer's instructions. BMDC pro-IL-1β production was assessed by quantitative reverse transcription PCR. RNA was isolated using the RNeasy isolation kit (Qiagen). Contaminating genomic DNA was digested using the Turbo DNA-free kit (Ambion) and RNA reverse transcribed with the Tetro cDNA synthesis kit (Bioline) according to the manufacturer's instructions. The resulting cDNA was purified using Qiagen's PCR purification kit. IL-1b gene expression was quantified by Quantitect Primer assay (Qiagen) using Sensifast SYBR & Fluorescein Mix (Bioline) using the Quantitect two-step amplification protocol. Gene expression was normalized to the S14 housekeeping gene (forward primer: TGGTGTCTGCCACATCTTTGCATC; reverse primer: AGTCACTCGGCAGATGGTTTCCTT).
Mice and infection. Experiments were carried out using sex-matched 8-to 12-week-old C57BL6, TLR2 −/− , TLR4 −/− and TLR5 −/− mice from the Jackson Laboratory. Experiments contained no fewer than four mice, with a goal of eight mice, per experimental group. Based on an expected protection from 50% to 0% mortality, six mice per group will have >90% power to detect a statistically significant difference in mortality. All animals were housed under specific pathogen-free conditions at the University of Virginia's animal facility, and procedures were approved by the Institutional Animal Care and Use Committee at the University of Virginia. No animals were excluded from the study, and sample harvesting was randomized between groups. Blinded scoring of animals was not possible because of the separate equipment used to prevent contamination between C. difficile strains. Before infection, bedding was exchanged every two days between TLR2 −/− and C57BL6 mice for a minimum of two weeks to equilibrate microbiota between strains. Mice were infected using a modified version of a previously published model for CDI 30 . Briefly, mice were given an antibiotic cocktail consisting of 45 mg l -1 vancomycin (Mylan), 35 mg l -1 colistin (Sigma), 35 mg l -1 gentamicin (Sigma), 215 mg l -1 metronidazole (Hospira) ad libitum for 3 days (days −6 to −4). Mice were then switched back to regular drinking water for two days (days −3 onward), followed by an intraperitoneal (IP) injection (0.032 mg g -1 ) of clindamycin (Hospira) on day −1. On day 0, mice were gavaged with C. difficile. Mice were monitored twice daily throughout the course of the infection and immediately euthanized if severe illness developed (according to clinical scoring parameters). Scores were based on weight loss, coat condition, activity level, diarrhoea, posture and eye condition for a cumulative clinical score between 1 and 20.
Tissue protein and histology. Mice were humanely euthanized and tissue was immediately removed for analysis. Total caecal lysate was generated by removing the caeca and rinsing gently with PBS. Tissue was bead beaten for 1 min in 400 µl of lysis buffer I (1× HALT protease inhibitor (Pierce), 5 mM HEPES). Lysis buffer II (400 µl) was added (1× HALT protease inhibitor (Pierce), 5 mM HEPES, 2% Triton X-100) and the tubes were inverted gently. Tissue samples were incubated on ice for 30 min, followed by a 5 min spin at 13,000g at 4°C. The supernatant was removed to a fresh tube, and total protein concentration was assessed by BCA assay according to the manufacturer's instructions (Pierce). Cytokine concentration is shown relative to total protein concentration. To generate histological sections, caecal samples were placed in Bouin's solution (Sigma) for 18 h. Tissue samples were moved to 70% ethanol before paraffin embedding and sectioning. Sections were mounted on slides and stained with H&E before microscopic examination. Slides were scored blinded, with a score from 0 to 3 assigned based on five parameters: epithelial disruption, submucosal edema, inflammatory infiltrate, mucosal thickening and luminal exudates (as previously reported 51 ) . Scores were averaged between three independent, blinded observers. Image manipulation was limited to movement of scale bars to the bottom left corner.
Eosinophil depletion. Eosinophils were depleted using an anti-mouse SiglecF monoclonal antibody (R&D Systems) as previously shown 33 . Control groups received Rag IgG2A isotype control antibody (R&D Systems). Both groups were given 40 µg of antibody per mouse on day −1 and day +1 of infection (80 µg total per mouse) via intraperitoneal injection. Eosinophil depletion was evaluated by flow cytometry, which showed an 82% average reduction in colonic eosinophils.
Eosinophil adoptive transfer. Bone marrow derived eosinophils were generated as previously described and examined on day 10 for eosinophil markers and viability via flow cytometry 52, 53 . Cultures routinely consisted of >75% live CD45 + CD11b + SiglecF + SSC hi eosinophils. For adoptive transfer, cultures were synchronized such that each injection occurred on day 10 of culture. Cultures were collecting using a cell scraper and washed twice in sterile PBS. A total of 4 × 10 5 eosinophils were given intraperitoneally per mouse. Mice received four total injections of eosinophils, starting the day before infection and for three subsequent days.
Statistical analysis. Statistical analysis was calculated and significance determined (P < 0.05) using the Mann-Whitney test or other suitable analysis, including Welch's t-test for unequal variance. All statistical analysis was performed using GraphPad Prism software.
Flow cytometry. Colonic lamina propria was prepared for flow cytometry by thoroughly rinsing the tissue in Hank's balanced salt solution (HBSS) supplemented with 5% FBS and 25 mM HEPES. Epithelial cells were removed by gentle shaking for 40 min at 37°C in HBSS with 15 mM HEPES, 5 mM EDTA, 10% FBS and 1 mM dithiothreitol. Halfway through the incubation, colon samples were transferred to fresh buffer. Next, colon samples were thoroughly chopped using scissors and digested in RPMI 1640 containing 0.17 mg ml -1 Liberase TL (Roche) and 30 µg ml -1 DNase (Sigma). Samples were digested for 40 min at 37°C with gentle shaking. Samples were then spun down at 300g and resuspended in HBSS with 5% FBS and 25 mM HEPES before passage through a 100 µM cell strainer followed by a 40 µM cell strainer (both Fisher Scientific). Cells were counted and the density adjusted to 1 × 10 7 cells per ml. Cell suspension (100 µl) was aliquoted into each well of a 96-well plate for antibody staining. For staining, cells were initially blocked with TruStain fcX (anti-mouse CD16/32 antibody, BioLegend) for 10 min at room temperature. Cells were spun down and resuspended in LIVE/DEAD Fixable Aqua (Life Technologies) for 20 min at room temperature. Cells were washed twice and stained with fluorochrome conjugated antibodies. Flow cytometry was performed on an LSR Fortessa cytometer (BD Biosciences) and all data analysis was performed via FlowJo (Tree Star). See Supplementary Table 1 for antibodies used.
